Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Accumulated Expenses (2017 - 2025)

Historic Accumulated Expenses for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $1.6 million.

  • Catheter Precision's Accumulated Expenses fell 8404.61% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 8404.61%. This contributed to the annual value of $1.5 million for FY2024, which is 1067.51% down from last year.
  • Catheter Precision's Accumulated Expenses amounted to $1.6 million in Q3 2025, which was down 8404.61% from $1.5 million recorded in Q2 2025.
  • Catheter Precision's 5-year Accumulated Expenses high stood at $9.8 million for Q3 2024, and its period low was $1.5 million during Q2 2025.
  • For the 5-year period, Catheter Precision's Accumulated Expenses averaged around $3.5 million, with its median value being $2.2 million (2021).
  • As far as peak fluctuations go, Catheter Precision's Accumulated Expenses soared by 45008.42% in 2024, and later crashed by 8404.61% in 2025.
  • Catheter Precision's Accumulated Expenses (Quarter) stood at $4.1 million in 2021, then soared by 81.69% to $7.5 million in 2022, then plummeted by 76.84% to $1.7 million in 2023, then dropped by 10.68% to $1.5 million in 2024, then grew by 0.97% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $1.5 million for Q2 2025, and $1.6 million during Q1 2025.